Philip J. Turner

In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I

Jeffrey R. Edwards, Philip J. Turner, C Wannop et al. · Antimicrobial Agents and Chemotherapy · 1989 · 118 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +15

Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003

Carlos Roberto Veiga Kiffer, André Hsiung, Carmen Paz Oplustil et al. · The Brazilian Journal of Infectious Diseases · 2005 · 87 citations · Full text

In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii

Carlos Roberto Veiga Kiffer, Jorge Luiz Mello Sampaio, Sumiko I. Sinto et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 77 citations

Medical Microbiology, Antimicrobial Susceptibility, Health Sciences +11

The MYSTIC (meropenem yearly susceptibility test information collection) programme

Philip J. Turner, Jeannette Greenhalgh, Jeffrey R. Edwards et al. · International Journal of Antimicrobial Agents · 1999 · 76 citations

Reliability, Diagnostic Criterion, Diagnosis +2

Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results

Philip J. Turner · Diagnostic Microbiology and Infectious Disease · 2007 · 75 citations

European Isolates, Disease Control, Disease Outbreak +8